Koeberl, D., Austin, S., Case, L., Smith, E. C., Buckley, A., Young, S. P., … Kishnani, P. S. (2014). Pilot study of adjunctive albuterol in late-onset Pompe disease reveals safety and efficacy from upregulated Mannose-6-phosphate receptor expression. In Molecular Genetics and Metabolism (Vol. 111, pp. S62–S62). Elsevier BV. https://doi.org/10.1016/j.ymgme.2013.12.137

Koeberl, Dwight, Stephanie Austin, Laura Case, Edward C. Smith, Anne Buckley, Sarah P. Young, Deeksha Bali, and Priya S. Kishnani. “Pilot study of adjunctive albuterol in late-onset Pompe disease reveals safety and efficacy from upregulated Mannose-6-phosphate receptor expression.” In Molecular Genetics and Metabolism, 111:S62–S62. Elsevier BV, 2014. https://doi.org/10.1016/j.ymgme.2013.12.137.

Koeberl D, Austin S, Case L, Smith EC, Buckley A, Young SP, et al. Pilot study of adjunctive albuterol in late-onset Pompe disease reveals safety and efficacy from upregulated Mannose-6-phosphate receptor expression. In: Molecular Genetics and Metabolism. Elsevier BV; 2014. p. S62–S62.

Koeberl, Dwight, et al. “Pilot study of adjunctive albuterol in late-onset Pompe disease reveals safety and efficacy from upregulated Mannose-6-phosphate receptor expression.” Molecular Genetics and Metabolism, vol. 111, no. 2, Elsevier BV, 2014, pp. S62–S62. Crossref, doi:10.1016/j.ymgme.2013.12.137.

Koeberl D, Austin S, Case L, Smith EC, Buckley A, Young SP, Bali D, Kishnani PS. Pilot study of adjunctive albuterol in late-onset Pompe disease reveals safety and efficacy from upregulated Mannose-6-phosphate receptor expression. Molecular Genetics and Metabolism. Elsevier BV; 2014. p. S62–S62.